IP Library › Granted Patent US 12,257,339
Granted Patent B2
US 12,257,339 · App. 17/441,224 · Granted Mar 25, 2025

Phytocomplex and extract of a meristematic cell line selected from a plant belonging to the genus

Inventors: Elena Sgaravatti (Padua, IT); Giovanna Pressi (Rubano, IT); Flavia Guzzo (Verona, IT)
Assignee: AETHERA BIOTECH S.R.L.
A61K8/9783A61K9/0014A61K36/738A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,257,339
App. No.
17/441,224
Granted
Mar 25, 2025
Kind
B2
Abstract

The present invention relates to a meristematic cell line selected from tissue, preferably callus tissue, of a plant belonging to the genus Rosa . The invention also relates to a derivative of the cell line, i.e. a phytocomplex or an extract of the cell line. The meristematic cell line is characterized by a high polysaccharide content. Furthermore, the present invention relates to the cosmetic, nutraceutical and medical use of the selected meristematic cell line or of a derivative thereof.

Claims (35)

1. A meristematic cell line derived from a plant belonging to the genus Rosa , wherein said cell line is obtained by means of a process comprising the steps of:

1) plating a tissue obtained from a plant of the genus Rosa onto a solid culture medium;

2) isolating a plurality of cellular clones;

3) inoculating each of the isolated clones into a liquid culture medium;

4) determining the polysaccharide content for each clone;

5) selecting the cellular clone with the highest polysaccharide content,

wherein the solid and liquid culture media comprise salts suitable for the growth of plant cells, sucrose, naphthylacetic acid (NAA) and 6-benzyl amino purine (BAP) and

wherein the meristematic cell line comprises an amount of polysaccharides greater than 25% w/w.

2. The meristematic cell line according to claim 1 , wherein the solid and liquid culture media each comprise sucrose in a concentration comprising 10 to 45 g/L.

3. The meristematic cell line according to claim 1 , wherein in both the solid and liquid culture media, the salts suitable for the growth of plant cells are selected from: CaCl 2 , KNO 3 , MgSO 4 , NaH 2 PO 4 , (NH 4 ) 2 SO 4 and combinations thereof.

4. The meristematic cell line according to claim 1 , wherein in both the solid and liquid culture media, the salts suitable for the growth of plant cells are selected from: CoCl 2 ·6H 2 O, CuSO 4 ·5H 2 O, NaEDTA·2H 2 O, FeSO 4 ·7H 2 O, H 3 BO 3 , KI, MnSO 4 ·H 2 O, Na 2 MoO 4 ·2H 2 O, ZnSO 4 ·7H 2 O and combinations thereof.

5. The meristematic cell line according to claim 1 , wherein both the solid and liquid culture media further comprise vitamins suitable for the growth of plant cells selected from:

myo-inositol, nicotinic acid, pyridoxine-HCl, thiamine-HCl and combinations thereof.

6. The meristematic cell line according to claim 3 , wherein both the solid and liquid culture media each comprise CaCl 2 in a concentration from 120 to 170 mg/L; KNO 3 in a concentration comprising 800 to 3700 mg/L; MgSO 4 in a concentration comprising 220 to 270 mg/L, NaH 2 PO 4 in a concentration comprising 100 to 180 mg/L; and (NH 4 ) 2 SO 4 in a concentration comprising 100 to 180 mg/L.

7. The meristematic cell line according to claim 4 , wherein the solid and liquid culture media each comprise CoCl 2 ·6H 2 O in a concentration comprising 0.01 to 0.05 mg/L; CuSO 4 ·5H 2 O in a concentration comprising 0.01 to 0.05 mg/L; NaEDTA·2H 2 O in a concentration comprising 20 to 60 mg/L; FeSO 4 ·7H 2 O in a concentration comprising 15 to 45 mg/L; H 3 BO 3 in a concentration comprising 1 to 7 mg/L; KI in a concentration comprising 0.1 to 2 mg/L; MnSO 4 ·H 2 O in a concentration comprising 5 to 20 mg/L; Na 2 MoO 4 ·2H 2 O in a concentration comprising 0.1 to 0.5 mg/L and ZnSO 4 ·7H 2 O in a concentration comprising 0.5 to 5 mg/L.

8. The meristematic cell line according to claim 5 , wherein both the solid and liquid culture media each comprise myo-inositol in a concentration comprising 70 to 130 mg;

pyridoxine-HCl from 70 to 130 mg; and thiamine-HCl from 5 to 20 mg/LL.

9. The meristematic cell line according to claim 1 , comprising an amount of medium molecular weight polysaccharides comprising 50% to 90%, relative to the total amount of polysaccharides.

10. The meristematic cell line according to claim 1 comprising an amount of low molecular weight polysaccharides comprising 20% to 30%, relative to the total amount of polysaccharides.

11. The meristematic cell line according to claim 1 , comprising an amount of polyphenols greater than 0.2%, relative to the dry mass of the cell line.

12. The meristematic cell line according to claim 11 , derived from the species Rosa canina , comprising an amount of polyphenols comprising 3% to 25%, relative to the dry mass of the cell line.

13. The meristematic cell line according to claim 11 , derived from the species Rosa chinensis , comprising an amount of polyphenols comprising 0.3% to 10%, relative to the dry mass of the cell line.

14. The meristematic cell line according to claim 1 , comprising proteins in an amount of from 10% to 40% w/w, lipids in an amount from 1% to 10% w/w relative to the dry mass of the cell line, and hydroxyproline in an amount comprising 0.1 to 1.3% w/w, relative to the dry mass of the cell line.

15. A composition comprising the meristematic cell line according to claim 1 .

16. The composition according to claim 15 , comprising the meristematic cell line in a concentration comprising 0.01% to 1% by weight, relative to the total composition.

17. The composition according to claim 15 , formulated as a cream, gel cream, gel, serum, oil, emulsion, emulsion gel (emulgel), ointment, eye drops, mouthwash, spray, preferably nasal spray, stick, pill, capsule, tablet, granular powder, hard-shelled capsule, orally dissolving granule, sachet, lozenge or liposome.

18. A meristematic cell line according to claim 1 , wherein the plant belongs to the species Rosa canina or to the species Rosa chinensis.

19. A meristematic cell line according to claim 1 , wherein the amount of polysaccharides comprises 25% to 70% w/w, relative to the dry mass of the cell line.

20. A process for preparing and selecting plant meristematic cells derived from a plant belonging to the genus Rosa , said cells having a polysaccharide content greater than 25% w/w relative to the dry mass of the cell line, said process comprising the steps of:

1) plating a tissue obtained from a plant of the genus Rosa , onto a solid culture medium;

2) isolating a plurality of cellular clones;

3) inoculating each of the isolated clones into a liquid culture medium;

4) determining the polysaccharide content for each clone;

5) selecting the cellular clone with the highest polysaccharide content,

wherein the solid and liquid culture media comprise salts suitable for the growth of plant cells, sucrose, naphthylacetic acid (NAA) and 6-benzyl-amino purine (BAP).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2024
From: SGARAVATTI, ELENA
To: AETHERA BIOTECH S.R.L.
Reel/Frame 069438/0228 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2022
From: PRESSI, GIOVANNA; GUZZO, FLAVIA
To: AETHERA BIOTECH S.R.L.
Reel/Frame 059139/0004 →
Priority Claims (1)
IT 102019000004105 · Mar 21, 2019 · national
Continuity (1)
Related Publication 20220175654A1 · Jun 9, 2022
References Cited (10)
US 20090208544A1 · Ennamany et al. · 2009 [cited by applicant]
US 20140356310A1 · Paris · 2014 [cited by examiner]
CN 107496346A · 2017 [cited by examiner]
WO 2013102882A2 · 2013 [cited by applicant]
Khosh-Khui et al.: “In Vitro Culture of the [cited by applicant]
Visessuwan et al.: “Plant regeneration systems from leaf segment culture through embryonic callus formation of Rosa hybrida and [cited by applicant]
Lattanzio et al.: “In vivo anti-inflammatory effect of Rosa canina L. extract”, Journal of Ethnopharmacology, Elsevier Ireland Ltd, IE, Feb. 1, 2021, pp. 880-885. [cited by applicant]
Cornelia et al.: “Potential of plant cells in culture for cosmetic application”, Phytochemistry Reviews, vol. 7, No. 3, Dec. 1, 2007, pp. 559-605. [cited by applicant]
Rout et al.: “Biotechnology of the rose: A review of recent progress”, Scientia Horticulturae, Elsevier, Amsterdam, NL, vol. 81, No. 3, Sep. 1, 1999, pp. 201-228. [cited by applicant]
International Search Report and Written Opinion for PCT/IB2020/052584, mailed May 29, 2020. [cited by applicant]